CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma ; volume:14 ; number:1 ; day:18 ; month:2 ; year:2015 ; pages:1-9 ; date:12.2015
Molecular cancer ; 14, Heft 1 (18.2.2015), 1-9, 12.2015
- Creator
-
Nymoen, Dag Andre
Holth, Arild
Hetland Falkenthal, Thea E.
Tropé, Claes G.
Davidson, Ben
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-015-0317-1
- URN
-
urn:nbn:de:101:1-2021081321340968121535
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nymoen, Dag Andre
- Holth, Arild
- Hetland Falkenthal, Thea E.
- Tropé, Claes G.
- Davidson, Ben
- SpringerLink (Online service)
Other Objects (12)
SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
Low-grade Serous Ovarian Carcinoma
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Notch signaling in serous ovarian cancer
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
Low-grade Serous Ovarian Carcinoma
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Notch signaling in serous ovarian cancer
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
Low-grade Serous Ovarian Carcinoma
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Role of integrins in the metastatic spread of high-grade serous ovarian cancer
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Notch signaling in serous ovarian cancer
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer